May 14, 2013 at 15:45 PM EDT
UPDATE: Jefferies Maintains Edwards Lifesciences at Buy on Promising Long-Term Opportuity
In a report published by Jefferies, analyst Raj Denhoy maintained a Buy rating on Edwards Lifesciences (NYSE: EW ) with a price target of $85.00. Denhoy stated in the report, "Edwards' Board has authorized a new $750 million buyback program, adding to $150 million remaining under the existing authorization
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here